Damascus-SANA

More than 2.3 million people around the world suffer from multiple sclerosis, an immune disease of the central nervous system that is more common in women.

World MS Day is an opportunity to address social barriers and bullying against people with MS, and aims to build communities that support and care for people with MS and promote self-care and healthy living with MS in people with MS.

In Syria, the Ministry of Health provides free treatment and diagnostic services for the disease through 7 specialized centers distributed in the governorates of Damascus, Homs, Hama, Aleppo, Tartous, Latakia and Sweida, according to unified drug treatment protocols that include 14 drug groups, according to the Director of Communicable and Chronic Diseases at the Ministry, Dr. Zuhair Al-Sahwi.

Al-Sahwi explained in a statement to SANA that the ministry has started giving the first dose of the drug "Cladrine" to patients with multiple sclerosis for free in the governorates of Damascus, Aleppo and Hama, and it will be distributed in the rest of the governorates later, noting that this drug is considered one of the most important and latest treatments for patients with multiple sclerosis as it is characterized by high effectiveness to control the disease, in addition to the ease of administration, as it is given orally for only several days in two consecutive years and is safe and has few side effects.

With regard to the symptoms of the disease, Dr. Al-Sahwi explained that they are embodied in a feeling of tingling or numbness in the limbs, imbalance, weakness or spasm in the muscles, confusion in vision, stress, difficulty speaking and affecting memory, pointing to the possibility of living with the disease and alleviating its symptoms in the event of early detection and early treatment to avoid complications.

Rama Rashidi

Follow SANA News on Telegram https://t.me/SyrianArabNewsAgency